TR3 death receptor expression in the normal and ischaemic brain

Neuroscience

Volumn 96, Issue 1, 2000, Pages 147-160

  Harrison, D C ^a   Roberts, J ^a   Campbell, C A ^a   Crook, B ^a   Davis, R ^a   Deen, K ^a   Meakin, J ^a   Michalovich, D ^a   Price, J ^a   Stammers, M ^a   Maycox, P R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Apo3L; Fas; Permanent middle cerebral artery occlusion; Stroke; TNF receptor; TR7

Indexed keywords

DEATH RECEPTOR TR3; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CELL DEATH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

AMINO ACID SEQUENCE; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BASE SEQUENCE; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBROVASCULAR ACCIDENT; HUMANS; IN SITU HYBRIDIZATION; MALE; MOLECULAR SEQUENCE DATA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; REFERENCE VALUES; TISSUE DISTRIBUTION;

EID: 0033967349     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00502-3     Document Type: Article

References (49)

1. Ashkenazi A., Dixit V.M. Death receptors: signalling and modulation. Science. 281:1998;1305-1308.
2. Ashkenazi A., Dixit V.M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11:1999;255-260.
3. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-α: a mediator of focal ischemic brain injury. Stroke. 28:1997;1233-1244.
4. Bodmer J.L., Burns K., Schneider P., Hofmann K., Steiner K., Thorne M., Bornand T., Hahne M., Schroter M., Becker K., Wilson A., French L.E., Browning J.L., MacDonald H.R., Tschopp J. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity. 6:1997;79-88.
5. NGFR) in the rat brain after focal cerebral ischemia. Molec. Med. 3:1997;765-781.
6. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:1996;788-794.
7. Casaccia-Bonnefil P., Kong H., Chao M.V. Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differentiation. 5:1998;357-364.
8. Charriaut-Marlangue C., Remolleau S., Aggoun-Zouaoui D., Ben-Ari Y. Apoptosis and programmed cell death: a role in cerebral ischemia. Biomed. Pharmacother. 52:1998;264-269.
9. Cheema Z.F., Wade S.B., Sata M., Walsh K., Sohrabji F., Miranda R.J. Fas/Apo-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-κB. J. Neurosci. 19:1999;1754-1770.
10. Chen J., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischaemia. J. Neurosci. 18:1998;4914-4928.
11. Chicheportiche Y., Bourdon P.R., Xu H.D., Hsu Y.M., Scott H., Hession C., Garcia I., Browning J.L. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. biol. Chem. 272:1997;32401-32410.
12. Chinnaiyan A.M., O'Rourke K., Yu G.-L., Lyons R.H., Garg M., Duan R., Xing L., Gentz R., Ni J., Dixit V.M. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science. 274:1996;990-992.
13. Dawson D.A., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci. Lett. 218:1996;41-44.
14. NGFR receptor. Nature. 383:1996;166-168.
15. Frade J.M., Barde Y.A. Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron. 20:1998;35-41.
16. Gary D.S., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. cerebr. Blood Flow Metab. 18:1998;1283-1287.
17. Harlow E. and Lane D. (eds) (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, New York.
18. Herdegen T., Claret F.-X., Kallunki T., Martin-Villalba A., Winter C., Hunter T., Karin M. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. 18:1998;5124-5135.
19. Jiang Y.P., Woronicz J.D., Liu W., Goeddel D.V. Prevention of constitutive TNF receptor 1 signalling by silencer of death domains. Science. 283:(5401):1999;543-546.
20. Johnson D.A., Lanahan C.R., Buck A., Sehgal A., Morgan C., Mercer E., Bothwell M., Chao M. Expression and structure of the human NGF receptor. Cell. 47:1986;545-554.
21. Kinouchi K., Brown G., Pasternak G., Donner D.B. Identification and characterisation of receptors for tumor necrosis factor-α in the brain. Biochem. biophys. Res. Commun. 181:1991;1532-1538.
22. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., Peter M.E. Cytotoxicity-dependent APO-1 (FAS/CD95)-associated proteins form a death inducing signalling complex (DISC) with the receptor. Eur. molec. Biol. Org. J. 14:1995;5579-5588.
23. Kitson J., Raven T., Jiang Y.-P., Goeddel D.V., Giles K.M., Pun K.-T., Grinham C.J., Brown R., Farrow S.N. A death-domain-containing receptor that mediates apoptosis. Nature. 384:1996;372-375.
24. Lavine S.D., Hofman F.M., Zlokovic B.V. Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J. cerebr. Blood Flow Metab. 18:1998;52-58.
25. Linnik M.D., Zobrist R.H., Hatfield M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 24:1993;2003-2008.
26. Linnik M.D., Miller J.A., Sprinkle-Cavallo J., Mason P.J., Thompson F.Y., Montgomery L.R., Schroeder K.K. Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion. Molec. Brain Res. 32:1995;116-124.
27. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
28. NGFR neutrophin receptor undergo neuronal apoptosis. J. Neurosci. 17:1997;6988-6998.
29. Marsters S.A., Sheridan J.P., Donahue C.J., Pitti R.M., Gray C.L., Goddard A.D., Bauer K.D., Ashkenazi A. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-KB. Curr. Biol. 6:1996;1669-1676.
30. Marsters S.A., Sheridan J.P., Pitti R.M., Brush J., Goddard A., Ashkenazi A. Identification of a ligand for the death domain-containing receptor APO3. Curr. Biol. 8:1998;525-528.
31. Martin-Villalba A., Hee I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T., Debatin K.-M. CD95 (Fas/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19:1999;3809-3817.
32. Matsuyama T., Hata R., Tagaya M., Yamamoto Y., Nakajima T., Furuyama J.-I., Wanaka A., Sugita M. Fas antigen mRNA induction in postischemic murine brain. Brain Res. 657:1994;342-346.
33. Matsuyama T., Hata R., Yamamoto Y., Tagaya M., Akita H., Uno H., Wanaka A., Furuyama J.-I., Sugita M. Localization of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridisation. Molec. Brain Res. 34:1995;166-172.
34. Meistrell M.E., Botchkina G.I., Wang H.C., Disanto E., Cockroft K.M., Bloom O., Vishnubhakat J.M., Ghezzi P., Tracey K.J. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock. 8:1997;341-348.
35. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K.J., Yuan J., Moskowitz M.A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
36. Oppenheim R.W. Cell death during development of the nervous system. A. Rev. Neurosci. 14:1991;453-501.
37. Orlinick J.R., Chao M.V. TNF-related ligands and their receptors. Cell. Signal. 10:1998;543-551.
38. Pan G.H., Bauer J.H., Haridas V., Wang S.X., Liu D., Yu G.L., Vincenz C., Aggarwal B.B., Ni J., Dixit V.M. Identification and functional characterisation of DR6, a novel death domain-containing TNF receptor. Fedn Eur. biochem. Socs Lett. 431:1998;351-356.
39. Pan G.H., Ni J., Wei Y.F., Yu G.L., Gentz R., Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 277:(5327):1997;815-818.
40. Pan G.H., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., Dixit V.M. The receptor for the cytotoxic ligand TRAIL. Science. 276:(5309):1997;111-113.
41. Patent EP 0 869 179 A1.
42. Pettmann B., Henderson C.E. Neuronal cell death. Neuron. 20:1998;633-647.
43. Screaton G.R., Xu X.-N., Olsen A.L., Cowper A.E., Tan R., McMichael A.J., Bell J.I. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. natn. Acad. Sci. U.S.A. 94:1997;4615-4619.
44. Shepard A.R., Rae J.L. Magnetic bead capture of cDNAs from double stranded plasmid cDNA libraries. Nucleic Acid Res. 25:1997;3183-3185.
45. Tan K.B., Harrop J., Reddy M., Young P., Terrett J., Emery J., Moore G., Truneh A. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene. 204:1997;35-46.
46. Tartaglia L.A., Ayres T.M., Wong G.H.W., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:1993;845-854.
47. Tschopp J., Irmler M., Thome M. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immun. 10:1998;552-558.
48. NGFR-deficient mice. Science. 274:(5293):1996;1729-1732.
49. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckman J.S., Mett I.L., Rebrikov D., Brodianski V.M., Kemper O.C., Kollet O., Lapidot T., Soffer D., Sobe T., Avraham K.B., Goncharov T., Holtmann H., Lonai P., Wallach D. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 9:1998;267-276.